We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

to review a copy of the book
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
recent work right here
The Medical News
LOS ANGELES (Reuters) - A multi-state E. coli outbreak that has sickened at least 19 people who ate rotisserie chicken salad sold at Costco Wholesale Corp's stores has been traced to a celery-and-onion mix used in the salad, prompting its California maker to recall the product.... (Reuters Health) - Many elementary school children with ADHD don’t get services like medication and behavior therapy that might improve their condition, according to an Australian study.... (Reuters Health) - If women are prone to “eat like a bird” when men are watching, men may be similarly programmed to “eat like a horse” when women are around, suggests a small U.S. study by behavioral scientists.... (Reuters Health) - After a year of treatment with the drug ranibizumab (Lucentis), some people with vision loss due to diabetes regain their confidence to drive and have vision good enough to do so, according to a new study.... (Reuters Health) - When two people follow the same weight-loss diet to the letter, but one fails to lose weight, the problem might be their bodies’ different responses to the same foods, a recent Israeli study suggests.... STOCKHOLM (Reuters) - The World Health Organization (WHO) said on Thursday that in 2014 it had recorded the highest number of new HIV cases in its European Region, which also includes Central Asia, since the start of reporting in the 1980s.... (Reuters) - A U.S. District Court on Wednesday denied specialty pharmacy Linden Care LLC's request for a temporary restraining order (TRO) against Express Scripts Holding Co for dropping it from its network earlier this month.... (Reuters Health) - People who speak two languages are twice as likely as those who only speak one to regain normal cognitive function after a stroke, according to a new study.... (Reuters Health) - Wheelchair users may be more likely to die in collisions with cars than other pedestrians, an analysis of U.S. crash data suggests.... (Reuters) - Amgen Inc on Wednesday said it filed with U.S. health regulators seeking approval to sell its first biosimilar drug, which would be a less expensive alternative to AbbVie's Humira, the world's top-selling prescription medicine.... (Reuters Health) - Particle pollution like soot is a known health hazard and linked to the risk of heart disease and stroke, but women with diabetes are even more vulnerable than most people, according to a new U.S. study.... (Reuters Health) - The price of many drugs prescribed by U.S. dermatologists has skyrocketed over the past six years, far exceeding increases in overall health care costs and stretching patients' budgets in an era of high insurance deductibles, according to a new study from Florida.... (Reuters Health) - Red meat – but not other types of protein - is linked to an increased stroke risk, and the odds go up the more meat people eat, a recent study suggests.... PARIS (Reuters) - France, the European Union's biggest agricultural producer, reported its first outbreak of the deadly H5N1 bird flu virus in eight years after detecting it in a backyard in a southwestern region home to many foie gras and poultry producers.... ZURICH (Reuters) - The European Union gave its green light to Roche's Cotellic for use in combination with the drug Zelboraf against advanced melanoma, the company said on Wednesday.... (Reuters) - Pfizer Inc said its blockbuster pain drug, Lyrica, had failed to show benefit in patients suffering from a type of post-traumatic nerve pain, in a late-stage study.... (This story filed on 24th November has been refiled to correct WHO quote to provide clarity on possible source of latest infection)... LONDON (Reuters) - Researchers voiced concern on Wednesday about poor quality studies on the popular ADHD treatment Ritalin, saying evidence of some benefits, but also of sleep problems and appetite loss, suggests the drug should be prescribed with caution.... LOS ANGELES (Reuters) - The former chief financial officer of a California hospital and four other people have been charged in a series of health care kickback schemes that generated nearly $600 million in fraudulent billings for spinal surgeries, prosecutors said on Tuesday.... (Reuters) - A panel of outside advisers to the U.S. Food and Drug Administration indicated that efficacy data from BioMarin Pharmaceutical Inc on its experimental drug for treating a muscle wastage disorder was not persuasive enough to warrant approval....